Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: Report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group

Hematology/ Oncology and Stem Cell Therapy

Volumn 4, Issue 2, 2011, Pages 81-93

  Mohamed, Said Yousef Ahmed ^a   Fadhil, Ibtihal ^b   Hamladji, Rose Marie ^c   Hamidieh, Amir Ali ^d   Fahmy, Omar ^e   Ladeb, Saloua ^f   Alimoghaddam, Kamran ^d   Elhaddad, Alaa ^e   Nacer, Redhouane Ahmed ^c   Alsharif, Fahad ^a   Rasheed, Walid ^a   Jahani, Mohammad ^d   Mousavi, Seyed Asadollah ^d   Alseraihy, Amal ^a   Abdel Rahman, Fawzi ^g   Al Jefri, Abdullah ^a   Hussein, Ayad Ahmed ^g   Alabdulaaly, Abdulaziz ^h   Ibrahim, Ahmad ⁱ   Bekadja, Mohamed Amine ^j   Abboud, Miguel ^k   Ahmed, Parvez ^l   Dennison, David ^m   Bakr, Mohammad ^a   Benchekroun, Said ⁿ   Hussain, Fazal ^a   Othman, Tarek Ben ^f   Aljurf, Mahmoud ^a   Ghavamzadeh, Ardeshir ^d   more..

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Centre Pierre et Marie Curie   (Algeria)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e CAIRO UNIVERSITY   (Egypt)

^f CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^g KING HUSSEIN CANCER CENTER   (Jordan)

^h The General Directorate of Armed Forces Health Services   (Saudi Arabia)

ⁱ MAKASSED GENERAL HOSPITAL   (Lebanon)

^j CHU Oran   (Algeria)

^k AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^l National University of Medical Sciences   (Pakistan)

^m SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

ⁿ Service d'Hematologie et Oncologie Pediatrique   (Morocco)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW DEPRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL PRACTICE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; HEALTH SURVEY; HEMOGLOBINOPATHY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMA CELL DYSCRASIA; REDUCED INTENSITY CONDITIONING; SIBLING; SOLID TUMOR; SOUTHERN EUROPE; TREATMENT INDICATION; TREATMENT RESPONSE; TREND STUDY; WORLD HEALTH ORGANIZATION;

EID: 79961005585     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.5144/1658-3876.2011.81     Document Type: Article

References (50)

1. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation(EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
2. http:CIBMTR.org. Visited 24/4/11.
3. Horowitz M. The role of registries in facilitating clinical research in BMT: examples from the Center for international Blood and Marrow Transplant Research. Bone Marrow Transplant. 2008; 42: S1-S2.
4. Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D, Joint Accreditation Committee of the international Society for Cellular Therapy (ISCT); European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008; 41: 687-705.
5. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation in Europe. Bone Marrow Transplantation 2005; 36: 575-590.
6. Tan SS, Uyl de-Groot CA, Huijgens PC, Fibbe WE. Stem cell transplantation in Europe: trends and prospects. Eur J Cancer. 2007; 43: 2359-65.
7. A Yoshimi, R Suzuki, Y Atsuta, M iida, D-P Lu, W Tong, A Ghavamzadeh, K Alimoghaddam, AKW Lie, R Liang, LL Chan, L Haipeng, P-L Tan, WYK Hwang, T-J Chiou, P-M Chen, T Van Binh, NN Minh, C-K Min, TJ Hwang and Y Kodera, on behalf of Asia-Pacific Blood and Marrow Transplantation Group (APBMT): Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplantation (2010) 45, 1682-1691.
8. http://www.who.org
9. Aljurf MD, Zaidi SZ, El Solh, et al. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transplant. 2009; 43: 1-12.
10. Saito AM, Cutler C, Zahrieh D, et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant. 2008; 14: 197-207.
11. Howard RJ. The challenging triangle: balancing outcomes, transplant numbers and costs. Am J Transplant. 2007; 7: 2443-5.
12. Stahl JE, Vacanti JP, Gazelle S. Assessing emerging technologies-the case of organ replacement technologies: volume, durability, cost. Int J Technol Assess Health Care. 2007; 23: 331-6.
13. H Baldomero, M Gratwohl, A Gratwohl, A Tichelli, D Niederwieser, A Madrigal and K Frauendorfer, for the European Group for Blood and Marrow Transplantation (EBMT). The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplantation (2011) 46, 485-501.
14. Ljungman P, Urbano-ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H et al., European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439-449.
15. Mahmoud H, El-Haddad AM, Fahmy O, et al. Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant. 2008; 42: S76-S80.
16. Shamsi T, Hashmi K, S Adil, et al. The stem cell transplant program in Pakistan-the first decade. Bone Marrow Transplant. 2008; 42:S114-S117.
17. Ben Othman T, Torjemane L, Abdelkefi A, et al. Allogeneic hematopoietic stem cell transplantation in Tunisia. Bone Marrow Transplant. 2008; 42: S139-S141.
18. F Abdel-Rahman F, Hussein A, Rihani R, Hlalah O, El Taani H, Sharma S, Nserat T, Sarhan M Bone marrow and stem cell transplantation at King Hussein cancer center. Bone Marrow Transplant. 2008; 42: S98-S91.
19. D Dennison, Al Kindi S, Pathare A, Daar S, Nusrat N, Rehman J, et al. Hematopoietic stem cell transplantation in Oman. Bone Marrow Transplant. 2008; 42: S109-S113.
20. Bazarbachi A, Hatoum H, Mugharbel A, Otrock Z, Yassine N, et al. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant. 2008; 42: S96-S102.
21. Benchekroun S, Harif M, Madani A, Quessar A, Zafad S, Rachid R. Present and future of hematology and stem cell transplantation in Morocco. Bone Marrow Transplant. 2008; 42: S106-S108.
22. Ghavamzadeh A, Alimogaddam K, Jahani M, et al. Hematopoietic stem cell transplantation in Iran. Hematol Oncol Stem Cel Ther. 2008; 1: 231-238.
23. Jawdat DM, Al Saleh S, Sutton P, Al Anazi H, Shubaili A, Tamim H, Hajeer AH. Chances of finding an HLA-matched sibling: The Saudi experience. Biol Blood Marrow Transplant. 2009 Oct; 15(10): 1342-4.
24. Ahmed SO, Ghavamzadeh A, Zaidi S, Baldomero H, Pasquini M, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud H, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M. Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007. Biol Blood Marrow Transplant. 2011 Mar 31.
25. Gratwohl A, Passweg J, Baldomero H et al for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilisation of haematopoietic stem cell transplants in Europe. Br J Haematol 2002; 117: 451-468.
26. http://www.census.gov
27. A Gratwohl, H Baldomero, K Frauendorfer and A Urbano-Ispizua, for the Joint Accreditation Committee of the international Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE). EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplantation (2006) 37, 1069-1085.
28. A Gratwohl, H Baldomero, A Schwendener, V Rocha, J Apperley, K Frauendorfer and D Niederwieser, for the Joint Accreditation Committee of the international Society for Cellular Therapy ISCT and the European Group for Blood and Marrow transplantation EBMT (JACIE). The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow transplantation (2009) 43, 275-291
29. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D, Joint Accreditation Committee of the international Society for Cellular Therapy ISCT; European Group for Blood and Marrow transplantation EBMT. Results of the EBMT activity survey 2005 on hematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39: 71-87.
30. Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A; European Group for Blood and Marrow transplantation (EBMT). Accreditation Committee. increased use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant. 2002 Dec; 30(12): 813-31.
31. Oliansky DM, Rizzo JD, Aplan PD, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 2007; 13: 1-25.
32. Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A, et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 2000; 355: 1393-8.
33. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant. 2006; 12: 1-30.
34. Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D; European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010 Feb; 45(2): 219-34.
35. Gupta V, Yi QL, Brandwein J, et al. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs. no donor comparison. Bone Marrow Transplant 2004; 33: 397-404.
36. S Saussele, R Hehlmann, A Gratwohl and A Hochhus: Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors. BMT 2011; 1
37. Palandri F, Castagnetti F, Testoni N, et al. Chronic myeloid leukemia in blast crisis treated with Imatinib 600 mg: outcome of the patients alive after a 6-year follow-up. Haematologica. 2008; 93(12): 1792-1796.
38. Hehlmann R, Saussele S. Treatment of chronic myeloid leukemia in blast crisis. Haematologica. 2008; 93(12): 1765-1769.
39. Ayas M, Al-Jefri A, Al-Seraihi A, Elkum N, Al-Mahr M, El-Solh H. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 years' experience. Bone Marrow Transplant 2008; 42: S45-S48.
40. Mahmoud H, Fahmy O, Kamel A, Kamel M, El-Haddad A, El-Kadi D. Peripheral bloodvs bone marrow as a source for allogeneic hematopoietic stem celltransplantation. Bone Marrow Transplant. 1999 Aug;24(4): 355-8.
41. Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Iravani M, Bahar B, Khodabandeh A, Khatami F, Gaffari F, Jalali A. Stem cell transplantation; iranianexperience. Arch iran Med. 2009 Jan; 12(1): 69-72. Erratum in: Arch Iran Med. 2009May;12(3): 329. Alimogaddam, Kamran [corrected to Alimoghaddam, Kamran]; Mousavi, Seyed Asadollah [corrected to Mousavi, Seied Asadollah].
42. Joan Blade, Laura Rosino, Maria Teresa Cibeira, Montserrat Rovira, and Enric Carreras. Hematopoietic stem cell transplantation for multiple myeloma beyond 2010. (Blood. 2010; 115(18): 3655-3663.
43. Shubham Pant, Edward A. Copelan Hematopoietic Stem Cell transplantation in Multiple Myeloma. Biology of Blood and Marrow Transplantation 13: 877-885 (2007).
44. Denise M. Oliansky, Myron Czuczman, Richard I. Fisher, Frank D. Irwin, Hillard M. Lazarus, James Omel, Julie Vose, Steven N. Wolff, Roy B. Jones, Philip L. McCarthy Jr., Theresa Hahn The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review. Biol Blood Marrow Transplant 17: 20-47 (2011)
45. Denise M. Oliansky, Leo I. Gordon, Jerry King, Ginna Laport, John P. Leonard, Peter McLaughlin, Robert J. Soiffer, Koen W. van Besien, Michael Werner, Roy B. Jones, Philip L. McCarthy, Jr., Theresa Hahn. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review Biol Blood Marrow Transplant 16: 443-468 (2010)
46. Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A Velardi A, Niederwieser D; European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 2010 Feb; 45(2): 219-34.
47. Barrett D, Fish JD, Grupp SA. Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. Pediatr Clin North Am. 2010 Feb; 57(1): 47-66. Review.
48. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, Niederwieser D. The EBMT activity survey 2008: impact of team size, team density and new trends. Bone Marrow Transplant 2011 Feb; 46(2): 174-91.
49. Gajewski JL, Lemaistre CF, Silver SM, et al. impending challenges in the hematopoietic stem cell transplantation workforce. Biol. Blood Marrow Transplant. 2009; 15: 1493-501.
50. Majhail NS, Murphy EA, Omondi NA, Robinett P, Gajewski JL, Lemaistre CF, Confer D, Rizzo JD. Allogeneic Transplant Physician and Center Capacity in the United States. Biol Blood Marrow Transplant. 2011 Apr 12.